Cho, H. S., Cho, H. S., Cho, H. S., Lee, S. K., Lee, S. K., Han, J. W., . . . Choi, J. Y. Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC. Frontiers Media S.A.
Chicago Style (17th ed.) CitationCho, Hee Sun, et al. Peripheral Blood Inflammatory Score Using a Cytokine Multiplex Assay Predicts Clinical Outcomes in Patients Treated with Atezolizumab-bevacizumab for Unresectable HCC. Frontiers Media S.A.
MLA (9th ed.) CitationCho, Hee Sun, et al. Peripheral Blood Inflammatory Score Using a Cytokine Multiplex Assay Predicts Clinical Outcomes in Patients Treated with Atezolizumab-bevacizumab for Unresectable HCC. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.